VETACE 2.5MG TABLETS FOR DOGS AND CATS Avustralya - İngilizce - APVMA (Australian Pesticides and Veterinary Medicines Authority)

vetace 2.5mg tablets for dogs and cats

zoetis australia pty ltd - benazepril hydrochloride - oral tablet - benazepril hydrochloride ungrouped active 2.5 mg/tb - cardiovascular system - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - chronic renal insufficiency | congestive heart failure | hypertrophic cardiomyopathy | dilated cardiomyopathy | mitral and/or tricuspid regur | valvular insufficiency

GAMUNEX  - C İsrail - İngilizce - Ministry of Health

gamunex - c

padagis israel agencies ltd, israel - immunoglobulins, normal human - solution for infusion - immunoglobulins, normal human 0.1 g/ml - immunoglobulins, normal human, for intravascular adm. - immunoglobulins, normal human, for intravascular adm. - gamunex is indicated as replacement therapy of primary immunodeficiency (pi) states in which severe impaiment of antibody forming capacity has been shown, such as congential agammaglobulinemia, common variable immunodeficiency, x-limked immunodeficiency with hyper igm, wiskott- aldrich syndrom, and severed combined immunodeficiencies. gamunex is also indicated in idiopathic thrombocytopenia purpura (itp) to raise platelet counts to prevent bleeding or to allow a patient with itp to undergo surgery.treatment of chronic inflammatory demyelinating polyneuropathy (cidp).

Nootropil (piracetam) 800 mg film-coated tablets Malta - İngilizce - Medicines Authority

nootropil (piracetam) 800 mg film-coated tablets

ucb pharma sa 60 allee de la recherche, b-1070 brussels, belgium - piracetam - film-coated tablet - piracetam 800 mg - psychoanaleptics

Avandamet Avrupa Birliği - İngilizce - EMA (European Medicines Agency)

avandamet

smithkline beecham plc - rosiglitazone, metformin hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes - avandamet is indicated in the treatment of type 2 diabetes mellitus patients, particularly overweight patients:who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone.in triple oral therapy with sulphonylurea in patients with insufficient glycaemic control despite dual oral therapy with their maximally tolerated dose of metformin and a sulphonylurea (see section 4.4).

UROMITEXAN mesna 600mg tablet blister pack Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

uromitexan mesna 600mg tablet blister pack

baxter healthcare pty ltd - mesna, quantity: 600 mg - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; calcium hydrogen phosphate dihydrate; maize starch; povidone; magnesium stearate; hypromellose; macrogol 6000; titanium dioxide; simethicone - for the reduction and prevention of urinary tract toxicity (haemorrhagic cystitis) of oxazaphosphorines (see adverse effects section of the cyclophosphamide and ifosfamide product information)

UROMITEXAN mesna 400mg tablet blister pack Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

uromitexan mesna 400mg tablet blister pack

baxter healthcare pty ltd - mesna, quantity: 400 mg - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; calcium hydrogen phosphate dihydrate; maize starch; povidone; magnesium stearate; hypromellose; macrogol 6000; titanium dioxide; simethicone - for the reduction and prevention of urinary tract toxicity (haemorrhagic cystitis) of oxazaphosphorines (see adverse effects section of the cyclophosphamide and ifosfamide product information)